NO ASSOCIATION BETWEEN INDOOR RADON AND CHILDHOOD LEUKEMIA IN FRECCLE (FINNISH REGISTER-BASED CASE-CONTROL STUDY OF CHILDHOOD LEUKEMIA)
EHA Library, Atte Nikkilä, 215727
CLARITHROMYCIN ADDED TO THE VCD REGIMEN CAUSES REDUCED HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE MYELOMA PATIENTS
EHA Library, Lene Kongsgaard Nielsen, 215728
RELINF PROJECT: PROSPECTIVE EPIDEMIOLOGICAL REGISTRY OF LYMPHOID NEOPLASMS IN SPAIN, ON BEHALF OF GELTAMO GROUP
EHA Library, Mariana Bastos Oreiro, 215729
A HEALTH STATE UTILITY MODEL ESTIMATING THE IMPACT OF IVOSIDENIB ON QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
EHA Library, Michael Storm, 215730
ASSESSMENT OF ADHERENCE IN HAEMOPHILIA PATIENTS - EVALUATION OF AN US INSTRUMENT AND DEVELOPMENT OF A NEW QUESTIONNAIRE FOR USE IN GERMANY
EHA Library, Sylvia von Mackensen, 215731
HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PEDIATRIC PATIENTS WITH RED CELL PYRUVATE KINASE DEFICIENCY
EHA Library, Paraskevi Klothaki, 215732
QUALITY OF LIFE IS REDUCED IN PATIENTS WITH (SUSPECTED) PLATELET FUNCTION DISORDERS
EHA Library, Maaike Blaauwgeers, 215733
PALLIATIVE CARE INDICATION IN ONCOHEMATOLOGIC PATIENTS: A COMPARISON TO SOLID TUMOR PATIENTS
EHA Library, Lucia Morais, 215734
COST PER MEDIAN MONTH OF PROGRESSION‐FREE SURVIVAL FOR DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE COMPARED WITH CARFILZOMIB PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Eric Maiese, 215735
EFFICACY AND SAFETY OF FACILITATED SUBCUTANEOUS IGG ADMINISTRATION IN PATIENTS WITH SECONDARY IMMUNODEFICIENCY DUE TO HEMATOLOGICAL MALIGNANCIES. A SINGLE-CENTER RETROSPECTIVE ANALYSIS.
EHA Library, Maria Dimou, 215736
IMPACT OF LOW GRADE ADVERSE EVENTS OF TYROSINE KINASE INHIBITORS ON THE QUALITY OF LIFE OF PATIENTS TREATED FOR CHRONIC MYELOID LEUKEMIA
EHA Library, S.M.Amine BENLAZAR, 215737
HEME-INDUCIBLE LIPID OXIDATION PATTERN SUPPORTS MONITORING OF CELL-FREE HEMOGLOBIN ACTIVITY IN PATIENTS WITH SICKLE CELL DISEASE.
EHA Library, Jeremy Deuel, 215738
COMPLEMENT ACTIVATION IN HOMOZYGOUS SICKLE CELL DISEASE PATIENTS IS MODULATED BY HYDROXYUREA
EHA Library, Lubka Roumenina, 215739
EARLY RECOGNITION OF THE SICKLING PROCESS OF ERYTHROCYTES BY LABEL-FREE LIGHT MICROSCOPIC IMAGING IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Irene Lorand-Metze, 215741
SICKLE CELL DISEASE SEVERITY MEASURE: DEVELOPMENT, TRANSLATION, AND PATIENT CULTURAL SENSITIVITY VALIDATION
EHA Library, Kenneth Bridges, 215742
IMPROVEMENT OF THE MULTIDISCIPLINARY MANAGEMENT OF SICKLE CELL DISEASE PATIENTS: IMPLEMENTATION OF A SICKLE CELL DISEASE PATIENT’S CLINICAL DATABASE: BELGIAN REGISTER OF SICKLE CELL DISEASE PATIENTS
EHA Library, Beatrice Gulbis, 215743
VARIATIONS IN COMPLICATIONS RELATED TO VASO-OCCLUSIVE CRISES AND HYDROXYUREA USE IN PATIENTS WITH SICKLE CELL DISEASE: OBSERVATIONS FROM STUDIES IN THE USA, SPAIN AND THE GULF REGION
EHA Library, Elena Cela, 215744
CORRELATION BETWEEN HEMOLYSIS AND HYPERCOAGULABILITY MARKERS AND EFFECTS OF HYDROXYUREA THERAPY IN SICKLE CELL PATIENTS
EHA Library, Maria de Fátima Sonati, 215745
INFLUENCE OF BCL11A POLYMORPHYSMS ON FETAL HEMOGLOBIN LEVELS AND HAEMOLYSIS MARKERS IN SICKLE CELL ANEMIA PEDIATRIC PATIENTS NOT RECEIVING HYDROXYUREA
EHA Library, Dalila Luciola ZANETTE, 215746
TICAGRELOR VERSUS PLACEBO FOR THE REDUCTION OF VASO-OCCLUSIVE CRISES IN PEDIATRIC SICKLE CELL DISEASE: DESIGN OF A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER PHASE 3 STUDY (HESTIA3)
EHA Library, Matthew Heeney, 215747
NOVEL TRIAL DESIGN TO EVALUATE ORAL VOXELOTOR FOR THE TREATMENT OF SICKLE CELL DISEASE: THE PHASE 3 HEMOGLOBIN OXYGEN AFFINITY MODULATION TO INHIBIT SICKLE HEMOGLOBIN POLYMERIZATION (HOPE) TRIAL
EHA Library, Kenneth I. Ataga, 215748
OUTCOME OF PHILADELPHIA CHROMOSOME-POSITIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS RECEIVING TYROSINE KINASE INHIBITOR MAINTENANCE THERAPY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Tuija Tapaninen, 215749
PD-1 OVEREXPRESSION ON BONE MARROW RESIDENT CD8+ MEMORY T-CELL SUBSETS COULD BE A PREDICTABLE MARKER FOR LEUKEMIA RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION.
EHA Library, Mikhail Drokov, 215750
OUTCOME OF SECOND SOLID CANCER AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: A COHORT STUDY ON 4065 PATIENTS ON BEHALF OF THE COMPLICATIONS AND QUALITY OF LIFE WORKING PARTY OF THE EBMT
EHA Library, André Tichelli, 215751
SIMILAR OUTCOMES OF REDUCED INTENSITY HAPLOIDENTICAL TRANSPLANTATION WHEN COMPARED TO MATCHED UNRELATED DONOR TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA. A JOINT ANALYSIS FROM CIBMTR-LC & EBMT-LWP.
EHA Library, Anna Sureda, 215752
TARGETING EXPANDED GUT HOMING EFFECTOR T CELL LINEAGES IN ACUTE INTESTINAL GRAFT VERSUS HOST DISEASE: IMPLICATIONS FOR VEDOLIZUMAB
EHA Library, Varun Mehra, 215753
ELTROMBOPAG TO IMPROVE PLATELET RECOVERY IN HAPLOIDENTICAL STEM CELL TRANSPLANTS (HAPLO-SCT): RESULTS OF A PHASE II TRIALPLUS A COMPARISON TO CONTROL PATIENTS
EHA Library, Uday Popat, 215754
ASSOCIATION OF SOCIO-ECONOMIC FACTORS WITH SURVIVAL OF PATIENTS WHO EXPERIENCE SEVERE CLASSIC ACUTE GVHD AFTER ALLO-HSCT. A RETROSPECTIVE STUDY BY THE TRANSPLANT COMPLICATIONS WORKING PARTY, EBMT
EHA Library, Andrzej Frankiewicz, 215755
COMPARISON OF REDUCED-INTENSITY CONDITIONING REGIMENS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA > 45 YEARS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION – A RETROSPECTIVE STUDY BY THE ALWP/EBMT
EHA Library, Zinaida Peric, 215756
A PHASE I/II TRIAL OF INTRAVENOUS AZACITIDINE FOR ACUTE GVHD PROPHYLAXIS IN PATIENTS UNDERGOING MATCHED UNRELATED STEM CELL TRANSPLANTATION: INTERIM PHASE II RESULTS
EHA Library, Mark Schroeder, 215757
BUSULFAN FLUDARABINE (BU-FLU) COMPARED TO THIOTEPA BUSULFAN FLUDARABINE (TBF) FOR ALLOGENEIC TRANSPLANTS IN ACUTE MYELOID LEUKEMIA (AML) OR REFRACTORY ANEMIA WITH EXCESS BLASTS (RAEB) IN REMISSION
EHA Library, Andrea Bacigalupo, 215758
EFFICACY AND SAFETY OF DEFIBROTIDE BY VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) DIAGNOSTIC CRITERIA IN AN EXPANDED-ACCESS (T-IND) STUDY
EHA Library, Selim Corbacioglu, 215759
PLASMA PRESEPSIN LEVEL IS A PREDICTIVE MARKER OF SEVERE ACUTE GVHD AFTER ALLO-HSCT: USEFULNESS AS A BIOMARKER OF ALLO-HSCT RELATED COMPLICATION
EHA Library, Tatsuo Oyake, 215760
ROLE OF IFN-GAMMA IN IMMUNE-MEDIATED GRAFT FAILURE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Pietro Merli, 215761
EFFECTS OF POST-AUTO-HSCT MRI BONE MARROW LESIONS ON PROGRESSION-FREE SURVIVAL IN PATIENTS WITH MM
EHA Library, Maxim Solovev, 215762
COMBINED EVALUATION OF DISEASE RISK INDEX AND ABCG2 EXPRESSION IDENTIFY AML PATIENTS AT A VERY HIGH RISK OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Daniela Damiani, 215763
AFTER ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION, A COMPOSITE SCORE BASED ON PLASMATIC LEVELS OF IL-2 RECEPTOR AND TIM-3, CAN PREDICT, AT DAY +18, TRM AND SEVERE A-GVHD
EHA Library, Giuseppe MILONE, 215764
A NEW ULTRASONOGRAPHY-BASED SCORING SYSTEM IS EFFECTIVE DIAGNOSTIC TOOL FOR SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Mutsumi Nishida, 215765
THE SIGNIFICANCE OF PERI-TRANSPLANTATION MINIMAL RESIDUAL DISEASE ASSESSED BY MULTIPARAMETER FLOW CYTOMETRY ON OUTCOMES FOR ADULT AML PATIENTS RECEIVING HAPLOIDENTICAL ALLOGRAFTS
EHA Library, Jing Liu, 215766
CHANGES IN THE NUMBER OF BONE MARROW LESIONS AND TUMOUR MASS ON MRI IN PATIENTS WITH MM FOLLOWING AUTO-HSCT
EHA Library, Maxim Solovev, 215767
ACUTE INTESTINAL GRAFT-VERSUS-HOST DISEASE AMONG PATIENTS UNDERGOING ALLOGENEIC CELL TRANSPLANT FOR HEMATOLOGICAL MALIGNANCY IN THE UNITED STATES: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
EHA Library, Aliki Taylor, 215768
ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA IN SWITZERLAND. 30 YEARS OF EXPERIENCE 1985-2017.
EHA Library, Stavroula Masouridi-Levrat, 215769
PHASE 2, OPEN-LABEL STUDY OF DEFIBROTIDE FOR PREVENTION OF ACUTE GVHD FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
EHA Library, Selim Corbacioglu, 215770
PROGNOSTICATION OF CHRONIC GRAFT VERSUS HOST DISEASE: THE IMPACT OF IMMUNE RECONSTITUTION.
EHA Library, Fabio Serpenti, 215771
UTILIZATION AND OUTCOMES OF FERTILITY PRESERVATION TECHNIQUES IN WOMEN UNDERGOING ALLOGENIC HEMATOPOIETIC CELL TRANSPLANT
EHA Library, Alexandra Higgins, 215772
LOW INCIDENCE OF SYMPTOMATIC OSTEONECROSIS AFTER ALLOGENEIC HSCT IN CHILDREN WITH HIGH-RISK OR RELAPSED ALL – RESULTS OF THE ALL-SCT 2003 TRIAL
EHA Library, Michaela Kuhlen, 215773
EARLY BLOOD STREAM INFECTION AFTER BMT IS ASSOCIATED WITH CYTOKINE DYSREGULATION AND POOR OVERALL SURVIVAL
EHA Library, Kate Markey, 215774
REGRESSION TREE BASED MODEL FOR PREDICTING NON-RELAPSE MORTALITY IN AML PATIENTS ALLO-TRANSPLANTED IN FIRST COMPLETE REMISSION
EHA Library, Anish Puliyayil, 215775
COMPARISON OF BUSULFAN/CYCLOPHOSPHAMIDE ALONE AND IN COMBINATION WITH THIOTEPA OR ANTI-THYMOCYTE GLOBULIN ON HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOME AMONG BETA-THALASSEMIA PATIENTS
EHA Library, Saqib Ansari, 215776
SECOND TRANSPLANT FOR PRIMARY GRAFT FAILURE , FOLLOWING HAPLOIDENTICAL GRAFTS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
EHA Library, SABRINA GIAMMARCO, 215777
SUBPOPULATIONS OF MONOCYTES AND B REGULATORY CELLS IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE
EHA Library, Drazen Pulanic, 215778
LIFESTYLE BEHAVIOR AMONG LYMPHOMA SURVIVORS AFTER HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Hanne Bersvendsen, 215779
CTLA-4 GENE POLIMORPHISM INFLUENCE THE OUTCOME OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Petra Kovy, 215780
ELDERLY PATIENTS WITH MULTIPLE MYELOMA: LONG-TERM OUTCOME FOLLOWING INDUCTION WITH NOVEL DRUGS AND AUTOLOGOUS STEM CELL TRANSPLANT
EHA Library, Swabirah Rassool, 215781
SEVERE PRE-ALLO-HSCT IRON OVERLOAD (IO), MEASURED BY LIVER MRI, SIGNIFICANTLY IMPAIRED THE PROCEDURE LONG-TERM OUTCOME
EHA Library, Juan Carlos Vallejo Llamas, 215782
INCIDENCE AND RISK FACTORS FOR THE DEVELOPMENT OF HEMORRHAGIC CYSTITIS ON HAPLOIDENTICAL TRANSPLANTATION
EHA Library, Cynthia ACOSTA FLEITAS, 215783
THREE MONTH FULL WHOLE BLOOD AND MIXED T CELL CHIMERISM IS ASSOCIATED WITH SUPERIOR OUTCOMES IN REDUCED-INTENSITY ALEMTUZUMAB-BASED ALLOGENEIC STEM CELL TRANSPLANTS FOR HAEMATOLOGICAL MALIGNANCIES
EHA Library, Alex Kanellopoulos, 215784
OUTCOMES OF SECOND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSE OF HEMATOLOGICAL DISEASES OR GRAFT FAILURE: A SINGLE-CENTRE EXPERIENCE
EHA Library, Monica Poiani, 215785
CLOFARABINE- BASED CYTOREDUCTIVE TREATMENT FOLLOWED BY MYELOABLATIVE CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN WITH HIGH-RISK, RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES.
EHA Library, DIEGO MEDINA VALENCIA, 215786
SELECTIVE INHIBITION OF OXIDATIVE PHOSPHORYLATION PREVENTS LETHAL GRAFT-VERSUS-HOST DISEASE WHILE MAINTAINING ANTITUMOR IMMUNITY
EHA Library, Zachariah McIver, 215787
AN UNBALANCED MONOCYTE MACROPHAGE POLARIZATION IN THE BONE MARROW MICROENVIRONMENT MAY CAUSE THE OCCURRENCE OF POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, HongYan Zhao, 215788
COMPLEMENT-RELATED GENETIC VARIANTS IN ADULT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS WITH TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY
EHA Library, Eleni Gavriilaki, 215789
MURINE MODELS FOR ESTABLISHING STEROID REFRACTORY GVHD
EHA Library, Tomomi Toubai, 215790
LOW-DOSE INTERLEUKIN-2 RESTORING HUMAN REGULATORY T CELL FUNCTION IN VITRO AS A POTENTIAL APPLICATION FOR GVHD THERAPY AFTER TRANSPLANTATION
EHA Library, Tzeon-Jye Chiou, 215791
HYPOFRACTIONATED TOTAL LYMPHOID IRRADIATION BY HELICAL TOMOTHERAPY AND HIGH DOSE CHEMOTHERAPY AS CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA
EHA Library, Fabio Guolo, 215792
THE RELATIONSHIP BETWEEN SELECTIVE PRE-TRANSPLANTATION IMMUNE PARAMETERS AND EARLY INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES UNDERGOING ASCT – PRELIMINARY REPORT
EHA Library, Agnieszka Szymczyk, 215793
SELECTIVE HSC-ABLATION USING ANTI-CD117 ANTIBODY DRUG CONJUGATE ENABLES SAFE AND EFFECTIVE AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Agnieszka Czechowicz, 215794
SERUM YKL-40 LEVELS IN PATIENTS WITH B-THALASSEMIA: RELATION TO VIRAL HEPATITIS, LIVER STIFFNESS AND HEPATIC IRON CONCENTRATION.
EHA Library, Samah Mostafa, 215795
THE STRONG LINK BETWEEN PANCREAS AND HEART IN THALASSEMIA MAJOR.
EHA Library, Alessia Pepe, 215796
A SIMPLE NGS METHOD FOR DETECTION OF MUTATIONS CAUSING ALPHA AND BETA THALASSEMIA
EHA Library, Mehmet Uzunel, 215797
PRE- AND POST-TRANSFUSION COMPLEMENT ACTIVATION IN TRANSFUSION-DEPENDENT Β-THALASSAEMIA
EHA Library, Eleni Gavriilaki, 215798
ASSOCIATION OF CLINICAL PHENOTYPE OF THALASSEMIA WITH COMMON FETAL HEMOGLOBIN VARIANTS IN LEBANESE PATIENTS BEARING THE CODON 29 ΒETA GENE MUTATION
EHA Library, Ali Taher, 215799
THALASSEMIA PREVENTION PROGRAM IN DEVELOPING WORLD SCENARIO: 13 YEARS EXPERIENCE
EHA Library, Kousar Perveen, 215800
ASSOCIATION OF VITAMIN D AND RETINOID X RECEPTORS EXPRESSION AND VITAMIN D BINDING PROTEIN VARIANTS WITH BONE DENSITY IN THALASSEMIA CHILDREN
EHA Library, shaimaa sahmoud, 215801
NEW OCCURRENCES OF MACROSCOPIC MYOCARDIAL FIBROSIS IN THALASSEMIA AT LONG TERM BY MULTIPLE FOLLOW-UP
EHA Library, Alessia Pepe, 215802
COMMON LINK BETWEEN BONE AND HEART HEALTH IN THALASSEMIA MAJOR.
EHA Library, Alessia Pepe, 215803
CEREBRAL IRON OVERLOAD IN BETA THALASSEMIA: DOES IT REALLY MATTER?
EHA Library, Immacolata Tartaglione, 215805
LEPTIN IS ASSOCIATED WITH THE DEGREE OF ANEMIA AND THE ERYTHROPOIETIN LEVELS IN Β THALASSEMIA PATIENTS
EHA Library, Carina Levin, 215806
MUTATION SPECTRUM IN HBB, HBA1 AND HBA2 GENES IN PATIENTS FROM EUROPEAN PART OF RUSSIA
EHA Library, Svetlana Mann, 215807
COMPREHENSIVE SCREENING FOR COEXISTING HETEROZYGOUS Α0-THALASSEMIA IN HEMOGLOBIN E TRAIT
EHA Library, Piroonrut Wongprachar, 215808
ARE ALL DIRECT ORAL ANTICOAGULANTS EQUAL TO SAFETY AND EFFICACY?
EHA Library, Begoña Navarro Almenzar, 215809
ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA AND ACUTE PANCREATITIS: VARIABLE AND RECIPROCAL PATHOPHYSIOLOGIC RELATIONSHIPS
EHA Library, Qian (Janie) Qin, 215810
EVALUATION OF LUPUS ANTICOAGULANT TESTING: A THREE YEAR EXPERIENCE
EHA Library, Isabel Izquierdo García, 215811
THE INFLUENCE OF PGP AND PGR PEPTIDES ON ANTICOAGULANT CAPACITY AND ANTITHROMBOTIC POTENTIAL OF BLOOD IN HEMOSTATIC DYSFUNCTION OF AGING RATS
EHA Library, Tamara Obergan, 215812
APTT-BASED CLOT WAVEFORM ANALYSIS IN VARIOUS INFECTIONS
EHA Library, Cheng Kiat Lawrence Ng, 215813
ANTITHROMBOTIC EFFECTS OF COMPLEX PREPARATIONS OF VEGETABLE HEPARINOID WITH LEUCINE
EHA Library, Ludmila Lyapina, 215814
C-TERMINAL FRAGMENTS OF NEUROPEPTIDES CHANGE INTERACTION OF BLOOD CELLS IN THROMBOGENESIS
EHA Library, Мария Golubeva, 215815
COMPARATIVE STUDY OF DALTEPARIN SODIUM AND ACETYLSALICYLIC ACID IN PREVENTION OF ANTIPHOSPHOLID SYNDROM ASSOTIATED WITH RECURRENT PREGNANCY MISCARRIAGE.
EHA Library, Dimitry Marinitch, 215816
LABORATORY CRITERIA FOR THE DIAGNOSTIC RELIABILITY OF TESTS FOR DETECTION OF LUPUS ANTICOAGULANT IN PATIENTS WITH SUSPECTED ANTIPHOSPHOLIPID SYNDROME
EHA Library, Valeriia Krasivska, 215817
THE COAGULATION SYSTEM FUNCTIONING IN PATIENTS WITH MYELOFIBROSIS
EHA Library, Elizaveta Efremova, 215818
PLATELET MAPPING BY THROMBOELASTOGRAPHY- ASSESSMENT OF PLATELET INHIBITION SECONDARY TO ANTIPLATELET THERAPY AFTER PCI
EHA Library, DIBYENDU DE, 215819
IMMATURE PLATELET FRACTION: A USEFUL MARKER FOR IDENTIFYING THE CAUSE OF THROMBOCYTOPENIA AND PREDICTING PLATELET RECOVERY
EHA Library, Eunyup Lee, 215820
PLATELETPHERESIS-ASSOCIATED LYMPHOPENIA IN FREQUENT PLATELET DONORS
EHA Library, John Gansner, 215821
INTRACRANIAL HEMORRHAGE IN LEUKEMIA PATIENTS: PRELIMINARY RESULTS OF AN ONGOING NESTED CASE CONTROL STUDY
EHA Library, Loes Cornelissen, 215822
QUALITY CONTROL IN CRYOPRESERVED POOLED PLATELETS: 9-YEAR EXPERIENCE IN A TRANSFUSION CENTRE.
EHA Library, Almudena Garcia Ruiz, 215823
BACTERIAL CONTAMINANTS AND BIOFILMS EFFECT PLATELET ACTIVATION AND FUNCTION: IMPLICATIONS IN PLATELET TRANSFUSIONS
EHA Library, Joels Wilson-Nieuwenhuis, 215824
ALLOIMMUNIZATION TO D AND NON-D RHESUS ANTIGENS INDUCED BY PLATELET TRANSFUSIONS
EHA Library, Michael Daskalakis, 215825
MASSIVE TRANSFUSION PROTOCOLS - FRIEND OR FOE ?
EHA Library, Moon Ley Tung, 215826
PLATELET-DERIVED MICROPARTICLES; THE EXPRESSION PROPERTIES AND POTENSIAL AS A SUBSTITUTE FOR PLATELETS
EHA Library, Shima Azadpour, 215827
MIR-497~195 CLUSTER IS ASSOCIATED WITH FAVORABLE OUTCOME AND HAS A TUMOR SUPPRESSIVE FUNCTION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Elena Boldrin, 215890

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings